Treatment of metastatic renal cancer with high-dose interleukin-2 after targeted therapy.

被引：0
|
作者：
Hawkins, Robert E.
Galvis, Victoria
Shanks, Jonathan
Dalal, Neha
Thistlethwaite, Fiona
Spencer-Shaw, Andrea
机构：
[1] Christie Canc Res UK, Manchester, Lancs, England
[2] Christie, Manchester, Lancs, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 05期
关键词：
D O I：
10.1200/jco.2012.30.5_suppl.439
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
439
引用
收藏
页数：1
相关论文
共 50 条
  • [11] The application of high-dose interleukin-2 for metastatic renal cell carcinoma
    David F. McDermott
    Medical Oncology, 2009, 26 : 13 - 17
  • [12] High Dose Interleukin-2 Therapy for Metastatic Renal Cell Carcinoma in the VEGF Targeted Era
    Fitzpatrick, A.
    Soosaipillai, G.
    Wilson, P.
    Powles, T.
    Shamash, J.
    CLINICAL ONCOLOGY, 2015, 27 (03) : E7 - E8
  • [13] Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer
    Yang, JC
    Sherry, RM
    Steinberg, SM
    Topalian, SL
    Schwartzentruber, DJ
    Hwu, P
    Seipp, CA
    Rogers-Freezer, L
    Morton, KE
    White, DE
    Liewehr, DJ
    Merino, MJ
    Rosenberg, SA
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (16) : 3127 - 3132
  • [14] REVERSIBLE CARDIOMYOPATHY AFTER HIGH-DOSE INTERLEUKIN-2 THERAPY
    GOEL, M
    FLAHERTY, L
    LAVINE, S
    REDMAN, BG
    JOURNAL OF IMMUNOTHERAPY, 1992, 11 (03): : 225 - 229
  • [15] High-dose interleukin-2 in metastatic disease: Renal cell carcinoma and melanoma
    Dutcher, J
    ONCOLOGY-NEW YORK, 2002, 16 (11): : 3 - 3
  • [16] Can outpatient interleukin-2 and interferon replace high-dose interleukin-2 for metastatic renal cell carcinoma?
    Johannes Vieweg
    Nature Clinical Practice Oncology, 2005, 2 : 192 - 193
  • [17] Can outpatient interleukin-2 and interferon replace high-dose interleukin-2 for metastatic renal cell carcinoma?
    Vieweg, J
    NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (04): : 192 - 193
  • [18] ACUTE MORPHINE INTOXICATION DURING HIGH-DOSE RECOMBINANT INTERLEUKIN-2 TREATMENT FOR METASTATIC RENAL-CELL CANCER
    BORTOLUSSI, R
    FABIANI, F
    SAVRON, F
    TESTA, V
    LAZZARINI, R
    SORIO, R
    DECONNO, F
    CARACENI, A
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (12) : 1905 - 1907
  • [19] OUTCOME OF HIGH-DOSE INTERLEUKIN-2 THERAPY FOR METASTATIC RENAL CELL CARCINOMA: SINGLE INSTITUTION EXPERIENCE
    Dudek, A. Z.
    Yee, H. O.
    Yee, R. T.
    Chereddy, S.
    Manivel, J. C.
    ANNALS OF ONCOLOGY, 2008, 19 : 196 - 197
  • [20] Fulminant myocarditis owing to high-dose interleukin-2 therapy for metastatic melanoma
    Thavendiranathan, P.
    Verhaert, D.
    Kendra, K. L.
    Raman, S. V.
    BRITISH JOURNAL OF RADIOLOGY, 2011, 84 (1001): : E99 - E102
12345